Patrick M Forde Selected Research

Patrick M Forde Research Topics

Disease

73	Neoplasms (Cancer) 03/2024 - 06/2012
51	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 06/2012
29	Lung Neoplasms (Lung Cancer) 11/2023 - 06/2012
10	Melanoma (Melanoma, Malignant) 10/2023 - 10/2012
9	Pneumonia (Pneumonitis) 10/2021 - 12/2018
7	Mesothelioma 01/2023 - 01/2019
6	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2020
5	Pathologic Complete Response 03/2024 - 09/2022
5	Disease Progression 01/2022 - 01/2018
4	Arthritis (Polyarthritis) 01/2022 - 01/2017
3	Residual Neoplasm 10/2023 - 01/2019
3	Malignant Mesothelioma 05/2022 - 11/2021
3	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2018
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 07/2015
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023 - 01/2022
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 01/2021
2	Esophageal Neoplasms (Esophageal Cancer) 06/2013 - 01/2013
2	Prostatic Neoplasms (Prostate Cancer) 01/2013 - 09/2012
1	Tertiary Lymphoid Structures 11/2023
1	Microsatellite Instability 10/2023
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Fatigue 01/2021
1	Aneuploidy (Aneuploid) 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Glioma (Gliomas) 01/2021
1	Human Influenza (Influenza) 01/2021
1	Anaplastic Thyroid Carcinoma 10/2020
1	Lymphocytosis 01/2020

Drug/Important Bio-Agent (IBA)

38	Immune Checkpoint InhibitorsIBA 03/2024 - 10/2012
16	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2019
11	NivolumabIBA 10/2023 - 12/2015
9	B7-H1 AntigenIBA 10/2023 - 01/2018
6	durvalumabIBA 02/2024 - 01/2021
5	Monoclonal AntibodiesIBA 01/2022 - 10/2012
5	AntibodiesIBA 01/2022 - 01/2013
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 10/2012
4	PlatinumIBA 02/2024 - 01/2018
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2023 - 01/2017
3	Anaplastic Lymphoma KinaseIBA 02/2024 - 06/2012
3	Tyrosine Kinase InhibitorsIBA 02/2024 - 08/2015
3	AntigensIBA 11/2023 - 01/2018
3	Cisplatin (Platino)FDA LinkGeneric 08/2023 - 01/2022
3	spartalizumabIBA 01/2021 - 01/2020
3	SteroidsIBA 01/2021 - 01/2020
3	IpilimumabIBA 01/2020 - 10/2012
2	Proteins (Proteins, Gene)FDA Link 10/2023 - 05/2018
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2023
2	Pemetrexed (MTA)FDA Link 01/2022 - 11/2021
2	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 01/2018
2	CytokinesIBA 01/2021 - 01/2018
2	Phosphotransferases (Kinase)IBA 01/2021 - 11/2017
2	LigandsIBA 12/2020 - 01/2014
2	ErbB Receptors (EGF Receptor)IBA 01/2018 - 08/2015
2	VaccinesIBA 03/2014 - 01/2013
2	Trastuzumab (Herceptin)FDA Link 06/2013 - 01/2013
1	monalizumabIBA 11/2023
1	InterferonsIBA 11/2023
1	Peptides (Polypeptides)IBA 10/2023
1	Granzymes (Granzyme)IBA 01/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 08/2022
1	Hematoxylin (Haematoxylon)IBA 08/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	AutoantibodiesIBA 01/2022
1	Rheumatoid FactorIBA 01/2022
1	mogamulizumabIBA 01/2022
1	cyclic citrullinated peptideIBA 01/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	osimertinibIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	pembrolizumabIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	avelumabIBA 01/2021
1	sabatolimabIBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021
1	T-DNAIBA 01/2021
1	Interleukin-7 (Interleukin 7)IBA 01/2021
1	Infliximab (Remicade)FDA Link 01/2021
1	atezolizumabIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	sintilimabIBA 10/2020
1	Chimeric Antigen ReceptorsIBA 09/2020
1	CTLA-4 AntigenIBA 09/2020
1	Prednisone (Sone)FDA LinkGeneric 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	3-chloro-2,5,6-trimethylbenzoateIBA 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020

Therapy/Procedure

47	Immunotherapy 02/2024 - 01/2013
45	Therapeutics 02/2024 - 06/2012
22	Drug Therapy (Chemotherapy) 03/2024 - 09/2012
8	Neoadjuvant Therapy 11/2023 - 01/2019
6	Radiotherapy 11/2023 - 01/2018
3	Adjuvant Chemotherapy 08/2023 - 01/2022
2	Castration 01/2013 - 09/2012
1	Fecal Microbiota Transplantation 10/2022
1	Chemoradiotherapy 09/2022
1	Duration of Therapy 01/2020